{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:19:29Z","timestamp":1790266769654,"version":"4.1.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      CD161, encoded by killer cell lectin-like receptor B1 gene, is a newly reported candidate inhibitor of tumour-infiltrating T cells. Antibody-mediated CD161 blockade enhances T cell-mediated killing of cancer cells\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      in several tumour types. We evaluated the role of CD161 using The Cancer Genome Atlas (TCGA) Pan-Cancer Data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CD161 expression was analysed using RNAseq data from TCGA and the Genotype-Tissue Expression (GTEx) database. HPA, GeneCards, and String database were used to explore the protein information of CD161. The prognostic value of CD161 was analysed using clinical survival data from the TCGA. Enrichment analysis of CD161 was conducted using the R package \u201cclusterProfiler\u201d. We downloaded the immune cell infiltration score of TCGA samples from published articles and online databases and performed a correlation analysis between immune cell infiltration levels and CD161 expression. We further assessed the association between CD161 and immune checkpoints, immune activating genes, immunosuppressive genes, chemokines, and chemokine receptors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>CD161 was differentially expressed and predicted better survival status in most tumour types in TCGA. In addition, CD161 expression was significantly associated with immunoregulatory interactions between lymphoid and non-lymphoid cells. CD161 expression was closely correlated with T cell infiltration, immune checkpoints, immune activating genes, immunosuppressive genes, chemokines, and chemokine receptors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>Our results suggest that CD161 is a potential cancer biomarker. CD161 might synergize with other immune checkpoints to regulate the immune microenvironment, which could be applied in the development of new-targeted drugs for immunotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Funding<\/jats:title>\n                    <jats:p>This work was supported by the National Nature Science Foundation of China (grant numbers 81773008, 81672756, 81872399, 81972897), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2015), the Natural Science Foundation of Guangdong Province (grant number 2017A030311023), the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program: 2017BT01S131 and the Guangzhou Technology Project (grant number 201804010044), National Key R&amp;amp;D Program of China (Grant Nos. 2020YFC2006400), Key-Area Research and Development Program of Guangdong Province (2019B020227004).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2021.688215","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T06:18:00Z","timestamp":1625811480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaohan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy335","article-title":"Association Between PD1 Mrna and Response to Anti-PD1 Monotherapy Across Multiple Cancer Types","volume":"29","author":"Par\u00e9","year":"2018","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.49864","article-title":"Development and Interpretation of a Pathomics-Based Model for the Prediction of Microsatellite Instability in Colorectal Cancer","volume":"10","author":"Cao","year":"2020","journal-title":"Theranostics"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46176","article-title":"Macrophage Correlates With Immunophenotype and Predicts Anti-PD-L1 Response of Urothelial Cancer","volume":"10","author":"Zeng","year":"2020","journal-title":"Theranostics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.613204","article-title":"CD8(+)Cd161(+) T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential","volume":"11","author":"Konduri","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-RW2021-027","article-title":"Inhibitory CD161 Receptor Is Expressed on Glioma-Infiltrating T Cells","year":"2021","journal-title":"Cancer Discov"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.022","article-title":"Inhibitory CD161 Receptor Identified in Glioma-Infiltrating T\u00a0Cells by Single-Cell Analysis","volume":"184","author":"Mathewson","year":"2021","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1423184","DOI":"10.1080\/2162402X.2017.1423184","article-title":"Expression of LLT1 and its Receptor CD161 in Lung Cancer Is Associated With Better Clinical Outcome","volume":"7","author":"Braud","year":"2018","journal-title":"Oncoimmunology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41698-020-00133-4","article-title":"The Identification and Functional Analysis of CD8+PD-1+CD161+ T Cells in Hepatocellular Carcinoma","volume":"4","author":"Li","year":"2020","journal-title":"NPJ Precis Oncol"},{"key":"B9","article-title":"Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) Interaction Enhances Natural Killer Cell-Mediated Lysis of Triple-Negative Breast Cancer Cells","volume":"8","author":"Marrufo","year":"2018","journal-title":"Am J Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.004","article-title":"The Immune Landscape of Cancer","volume":"51","author":"Thorsson","year":"2019","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"Clusterprofiler: An R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ccell.2017.05.010","article-title":"Snapshot: Immune Checkpoint Inhibitors","volume":"31","author":"Abril-Rodriguez","year":"2017","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11912-018-0718-6","article-title":"Immune Checkpoint Inhibitor Toxicity","volume":"20","author":"Palmieri","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S274913","article-title":"PD-L1 Expression Is Highly Associated With Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma","volume":"12","author":"Deng","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000340","article-title":"ATR Inhibitor AZD6738 Enhances the Antitumor Activity of Radiotherapy and Immune Checkpoint Inhibitors by Potentiating the Tumor Immune Microenvironment in Hepatocellular Carcinoma","volume":"8","author":"Sheng","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41419-020-2403-6","article-title":"CD73 Promotes Tumor Metastasis by Modulating RICS\/RhoA Signaling and EMT in Gastric Cancer","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.coi.2006.03.011","article-title":"Immune Synapses in T-Cell Activation","volume":"18","author":"Cemerski","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.375","article-title":"The Immunological Synapse","volume":"19","author":"Bromley","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2006.03.013","article-title":"B Cell Recognition of Membrane-Bound Antigen: An Exquisite Way of Sensing Ligands","volume":"18","author":"Carrasco","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-052977","article-title":"Reciprocal Regulation of Human Natural Killer Cells and Macrophages Associated With Distinct Immune Synapses","volume":"109","author":"Nedvetzki","year":"2007","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ni1582","article-title":"Functions of Natural Killer Cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-Mediated Ferroptosis Dampens Intratumoral CD8(+) T\u00a0Cell Effector Function and Impairs Their Antitumor Ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12954","article-title":"Runx Proteins and Transcriptional Mechanisms That Govern Memory CD8 T Cell Development","volume":"300","author":"Pipkin","year":"2021","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature08511","article-title":"CD8(+) T Lymphocyte Mobilization to Virus-Infected Tissue Requires CD4(+) T-Cell Help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13656","article-title":"Targeting Regulatory T Cells in Tumors","volume":"283","author":"Liu","year":"2016","journal-title":"FEBS J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T Cells in Cancer Immunosuppression - Implications for Anticancer Therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.622509","article-title":"Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.688215\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T06:18:04Z","timestamp":1625811484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.688215\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2021.688215"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.688215","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"article-number":"688215"}}